China’s SFDA Orders Special Safety Of Drug Supply In Earthquake Wake
This article was originally published in PharmAsia News
China's State FDA has ordered local governments to provide daily reports on the production, safety and supply of drugs as the country deals with a devastating earthquake. The agency ordered all those involved in food and drug safety to 24-hour duty to oversee drugs and medical facilities intended for disaster relief. The workers are to crack down on production and sale of fake drugs and non-affected provinces were ordered to transfer some of their drug supplies and facilities to the disaster-hit areas. (Click here for more
You may also be interested in...
Having licensed rights to Movantik from AstraZeneca in February, RedHill has now offloaded EU rights to Cosmo. Calliditas to obtain PBC candidate in bid to acquire Genkyotex.
Many materials subject to order, APIs needed for OTC as well as Rx drugs, are supplied by companies outside the US, and China accounts for the bulk of them. The order didn't specify countries and products, leaving decisions to FDA.
Order sets a path for federal government to use its power as a purchaser of pharmaceuticals to nurture a high-tech domestic pharma manufacturing sector that would increase resilience against threats that could isolate the US from countries like China that are important nodes in the global manufacturing supply chain.